Product/Composition:- | Bisoprolol tablets |
---|---|
Strength:- | 2.5 mg, 5 mg, 10 mg |
Form:- | Tablet |
Reference Brands:- | Zebeta, Monocor(US); Concor(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Bisoprolol is a selective beta-1 blocker that reduces heart rate, blood pressure, and myocardial oxygen demand by blocking adrenaline effects on the heart. It effectively manages hypertension, angina, and heart failure. Benefits include improved cardiovascular stability, symptom control, decreased risk of heart attacks, and enhanced overall heart health.
Bisoprolol tablets, marketed as Zebeta and Concor, are approved in the US by the FDA and in the EU via EMA for hypertension, angina, and heart failure. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The US FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Regional compliance supports prompt approval, safe use, and broader availability, helping improve cardiovascular outcomes and quality of life worldwide.